Psychosocial Factors and Adherence to Continuous Glucose Monitoring in Type 1 Diabetes

Bergenstal RM Tamborlane WV Ahmann A Buse JB Dailey G Davis SN Joyce C Peoples T Perkins BA Welsh JB Willi SM Wood MA ; STAR 2 Study Group. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363 (4): 311–20. Epub 2010 Jun 29.

Hermanides J Nørgaard K Bruttomesso D Mathieu C Frid A Dayan CM Diem P Fermon C Wentholt IM Hoekstra JB DeVries JH . Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial. Diabet Med. 2011;28 (10): 1158–67. doi: 10.1111/j.1464-5491.2011.03256.x.

Pickup JC Freeman SC Sutton AJ . Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: Meta-analysis of randomised controlled trials using individual patient data. BMJ. 2011;343: d3805. doi: 10.1136/bmj.d3805.

Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Beck RW Buckingham B Miller K Wolpert H Xing D Block JM Chase HP Hirsch I Kollman C Laffel L Lawrence JM Milaszewski K Ruedy KJ Tamborlane WV . Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care. 2009;32 (11): 1947–53. Epub 2009 Aug 12.

Ramchandani N Arya S Ten S Bhandari S . Real-life utilization of real-time continuous glucose monitoring: The complete picture. J Diabetes Sci Technol. 2011;5 (4): 860–70.

Ritholz MD Atakov-Castillo A Beste M Beverly EA Leighton A Weinger K Wolpert H . Psychosocial factors associated with use of continuous glucose monitoring. Diabet Med. 2010;27 (9): 1060–5.